Skip to main content
In stock|Targeted Therapy

PF-06821497 (EZH2 Inhibitor)

Oncology TypeHematologic
Drug Class / MechanismEZH2 Inhibitor
No Image
Description

PF-06821497 (EZH2 Inhibitor) is classified as an EZH2 Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy
Oncology TypeHematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3